D-0544-2018 Class II Terminated
FDA drug recall D-0544-2018 was initiated by Apace KY LLC on Feb 9, 2018 and is designated Class II. Reason for recall: Presence of Foreign Tablet/Capsule; cartons labeled to contain Acyclovir tablets may contain Torsemide tablets in some of the blister cavities. The recall status is terminated (terminated Sep 10, 2019). Affected quantity: 630 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 7, 2018
- Initiation Date
- Feb 9, 2018
- Termination Date
- Sep 10, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 630 cartons
Product description
Acyclovir Tablets, USP, 400 mg, 50 Tablets (5 x 10) unit dose blisters [NDC 50268-061-11] per carton [NDC 50268-061-15], Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478
Reason for recall
Presence of Foreign Tablet/Capsule; cartons labeled to contain Acyclovir tablets may contain Torsemide tablets in some of the blister cavities.
Distribution pattern
Nationwide
Code information
Lot: 19900, exp 05/2019
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0544-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026